YAEL KUSHNER: Open Payments
NPI 1730433483 · FT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 32 payments from 14 companies in 2025. Trend: 2023 $942 · 2024 $1,426 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $163 |
| GlaxoSmithKline, LLC. | 9 | $153 |
| Genentech, Inc. | 1 | $139 |
| CSL Behring | 2 | $127 |
| Organon LLC | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Boston Scientific Corporation | 1 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Amgen Inc. | 2 | $47 |
| Grifols USA, LLC | 1 | $26 |
Products named: DUPIXENT, Xolair, Hizentra, TRELEGY ELLIPTA, NUCALA, AMS 700, TEZSPIRE, Prolastin-C Liquid.
Industry payments across FL — which companies pay providers there.
